Literature DB >> 11518655

Histologic study of effects of radiation synovectomy with Rhenium-188 microsphere.

S J Wang1, W Y Lin, M N Chen, J T Chen, W L Ho, B T Hsieh, H Huang, L H Shen, G Ting, F F Knapp.   

Abstract

Rhenium-188 microsphere is a relatively new radiation synovectomy agent developed for the treatment of rheumatoid arthritis. It has been shown that the levels of unwanted extra-articular radiation are negligible with this agent. A histologic study was conducted to assess the effect of radiation synovectomy on synovium and articular cartilage after intra-articular injection of various doses of Re-188 microspheres into the knee joints of rabbits. Intra-articular injection of Re-188 microspheres into rabbit knee joints resulted in mild reactive inflammation and thrombotic occlusion of vessels which subsided rapidly. Sclerosis of subsynovium could be seen 12 weeks after injection. No evidence of damage to articular cartilage was noted. There was no significant difference in the articular pattern after injection of 0.3 or 0.6 mCi Re-188 microspheres. This study suggests that a treatment dose of Re-188 microspheres causes transient inflammation of synovium without any detectable damage to the articular cartilage of knee joint.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518655     DOI: 10.1016/s0969-8051(01)00228-1

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  2 in total

1.  Role of radiosynovectomy in the treatment of rheumatoid arthritis and hemophilic arthropathies.

Authors:  Bk Das
Journal:  Biomed Imaging Interv J       Date:  2007-10-01

2.  The EANM guideline for radiosynoviorthesis.

Authors:  W U Kampen; B Boddenberg-Pätzold; M Fischer; M Gabriel; R Klett; M Konijnenberg; E Kresnik; H Lellouche; F Paycha; L Terslev; C Turkmen; F van der Zant; L Antunovic; E Panagiotidis; G Gnanasegaran; T Kuwert; T Van den Wyngaert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-20       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.